Maqueta Endpoints

About Us

Accelerating Innovative Treatments and Driving Impact in Latin America

EndPoints is a top-tier network of clinical research centers in Latin America. We lead the way in delivering high-quality clinical, epidemiological, and public health research—helping transform science into real health solutions.

With 100+ trials completed, 50,000+ participants enrolled, and partnerships with 30+ global sponsors, our network is powered by 400+ experts across 9 centers of excellence in Panama, Colombia, and Guatemala

Therapeutic Focus

Infectious Diseases and Vaccines

COVID-19, RSV, Dengue, Poliovirus, Norovirus, Influenza, Pneumococcus, Chikungunya, HIV, Meningitis, Hepatitis A, Herpesvirus, HPV, Pertussis, Varicella, Zika Virus, others.

Cardiology

Hypertension, Dyslipidemia, Heart failure, Arrhythmias, Post-acute MI, Devices

Endocrinology and Metabolism

Diabetes, Obesity, Other Hormonal Disorders

Neurology and Psychiatry

Depression, Epilepsy, Migraine, Alzheimer’s Disease, Parkinson’s Disease

Experience
Snapshot

100+
Clinical Trials

50,000+
Participants

30+
Sponsors and CROs

400+
Experts

9
Clinical Research Centers

<4%
Drop-Off Rate

We are
LATAM´s Benchmark

Faster, smarter feasibility through advanced data tools

Centralized start-up and streamlined site activation

A single point of contact for seamless collaboration

Networked centers, aligned on quality and process

Our Network

Proven Impact

We’ve helped develop 15+ approved vaccines, collaborated with WHO, NIH, and top pharma companies, and consistently delivered on quality—with zero critical audit findings, including from the FDA.